Anebulo Pharmaceuticals I... (ANEB)

1.13

-0.03 (-2.59%)

At close: Mar 03, 2025, 3:59 PM

1.11

-1.77%

After-hours: Mar 03, 2025, 04:00 PM EST

Anebulo Pharmaceuticals Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20
Net Income	-8.2M	-11.73M	-6.83M	-30.25M	-174.64K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	758.88K	884.72K	480.66K	199.95K	n/a
Other Working Capital	-421.14K	-153.72K	637K	-1.56M	22.58K
Other Non-Cash Items	151.23K	731.01K	209.88K	26.63M	1.29K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-799.26K	1.16M	907.78K	-1.45M	22.58K
Operating Cash Flow	-8.09M	-9.68M	-5.44M	-4.87M	-150.77K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	-201.29K	200K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-62.35K	-264.68K	n/a	-821.63K	n/a
Financial Cash Flow	-62.35K	6.38M	n/a	21.83M	3.18M
Net Cash Flow	-8.15M	-3.3M	-5.44M	16.96M	3.02M
Free Cash Flow	-8.09M	-9.68M	-5.44M	-4.87M	-150.77K